Mather Group LLC. Sells 128 Shares of Intuitive Surgical, Inc. $ISRG

Mather Group LLC. decreased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.6% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,643 shares of the medical equipment provider’s stock after selling 128 shares during the quarter. Mather Group LLC.’s holdings in Intuitive Surgical were worth $1,436,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of the business. Brighton Jones LLC raised its position in shares of Intuitive Surgical by 24.9% during the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after acquiring an additional 731 shares during the last quarter. PKO Investment Management Joint Stock Co bought a new stake in Intuitive Surgical in the fourth quarter valued at about $1,566,000. Lansforsakringar Fondforvaltning AB publ acquired a new position in Intuitive Surgical in the fourth quarter valued at about $109,345,000. Wealth Enhancement Advisory Services LLC raised its position in shares of Intuitive Surgical by 69.4% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 264,033 shares of the medical equipment provider’s stock valued at $137,814,000 after acquiring an additional 108,153 shares during the period. Finally, 111 Capital acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at $1,173,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Stock Down 0.8%

Shares of ISRG stock opened at $443.99 on Thursday. The firm has a market cap of $159.16 billion, a PE ratio of 61.92, a P/E/G ratio of 4.69 and a beta of 1.61. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00. The company’s fifty day simple moving average is $472.54 and its 200-day simple moving average is $502.13.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The firm had revenue of $2.44 billion for the quarter, compared to analysts’ expectations of $2.35 billion. During the same period in the previous year, the firm posted $1.78 EPS. The company’s revenue for the quarter was up 21.4% on a year-over-year basis. On average, equities analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several analysts recently commented on ISRG shares. Evercore ISI raised their price objective on Intuitive Surgical from $470.00 to $550.00 and gave the stock an “in-line” rating in a research note on Tuesday, July 8th. Truist Financial lifted their price objective on Intuitive Surgical from $590.00 to $600.00 and gave the company a “buy” rating in a report on Wednesday, July 23rd. BTIG Research boosted their price objective on Intuitive Surgical from $566.00 to $571.00 and gave the company a “buy” rating in a research report on Wednesday, July 23rd. UBS Group raised their target price on shares of Intuitive Surgical from $547.00 to $585.00 and gave the stock a “neutral” rating in a report on Wednesday, July 23rd. Finally, Zacks Research cut shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Wednesday, August 20th. Thirteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $595.95.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, insider Gary S. Guthart sold 29,360 shares of the company’s stock in a transaction on Friday, August 29th. The shares were sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the sale, the insider directly owned 19,827 shares of the company’s stock, valued at approximately $9,368,059.23. This represents a 59.69% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Amy L. Ladd sold 335 shares of the stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $440.69, for a total transaction of $147,631.15. Following the completion of the sale, the director owned 739 shares of the company’s stock, valued at approximately $325,669.91. This represents a 31.19% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 45,224 shares of company stock worth $21,716,492 in the last 90 days. Corporate insiders own 0.70% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.